Medpace Inc. (MEDP)
Medpace Statistics
Share Statistics
Medpace has 28.74M shares outstanding. The number of shares has increased by -1.67% in one year.
| Shares Outstanding | 28.74M |
| Shares Change (YoY) | -1.67% |
| Shares Change (QoQ) | -1.98% |
| Owned by Institutions (%) | 81.73% |
| Shares Floating | 23.28M |
| Failed to Deliver (FTD) Shares | 8.43K |
| FTD / Avg. Volume | 1.66% |
Short Selling Information
The latest short interest is 2.03M, so 7.07% of the outstanding shares have been sold short.
| Short Interest | 2.03M |
| Short % of Shares Out | 7.07% |
| Short % of Float | 8.9% |
| Short Ratio (days to cover) | 3.01 |
Valuation Ratios
The PE ratio is 25.43 and the forward PE ratio is 22.52. Medpace's PEG ratio is 0.61.
| PE Ratio | 25.43 |
| Forward PE | 22.52 |
| PS Ratio | 4.88 |
| Forward PS | 2.5 |
| PB Ratio | 12.46 |
| P/FCF Ratio | 16.89 |
| PEG Ratio | 0.61 |
Enterprise Valuation
Medpace has an Enterprise Value (EV) of 9.74B.
| EV / Sales | 4.62 |
| EV / EBITDA | 21.8 |
| EV / EBIT | 16 |
| EV / FCF | 16 |
Financial Position
The company has a current ratio of 0.93, with a Debt / Equity ratio of 0.15.
| Current Ratio | 0.93 |
| Quick Ratio | 0.93 |
| Debt / Equity | 0.15 |
| Debt / EBITDA | 0.28 |
| Debt / FCF | 0.21 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is 48.98% and Return on Invested Capital is 38.11%.
| Return on Equity | 48.98% |
| Return on Assets | 19.25% |
| Return on Invested Capital | 38.11% |
| Revenue Per Employee | $357.47K |
| Profits Per Employee | $68.54K |
| Employee Count | 5,900 |
| Asset Turnover | 1 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 71.54M |
| Effective Tax Rate | 15.03% |
Stock Price Statistics
The stock price has increased by -22.46% in the last 52 weeks. The beta is 1.46, so Medpace's price volatility has been higher than the market average.
| Beta | 1.46 |
| 52-Week Price Change | -22.46% |
| 50-Day Moving Average | 314.51 |
| 200-Day Moving Average | 343.5 |
| Relative Strength Index (RSI) | 52.68 |
| Average Volume (20 Days) | 509.05K |
Income Statement
In the last 12 months, Medpace had revenue of 2.11B and earned 404.39M in profits. Earnings per share was 13.06.
| Revenue | 2.11B |
| Gross Profit | 656.3M |
| Operating Income | 446.87M |
| Net Income | 404.39M |
| EBITDA | 446.87M |
| EBIT | 446.87M |
| Earnings Per Share (EPS) | 13.06 |
Balance Sheet
The company has 669.44M in cash and 126.23M in debt, giving a net cash position of 543.2M.
| Cash & Cash Equivalents | 669.44M |
| Total Debt | 126.23M |
| Net Cash | 543.2M |
| Retained Earnings | 8.17M |
| Total Assets | 1.9B |
| Working Capital | 810.72M |
Cash Flow
In the last 12 months, operating cash flow was 608.82M and capital expenditures 0, giving a free cash flow of 608.82M.
| Operating Cash Flow | 608.82M |
| Capital Expenditures | 0 |
| Free Cash Flow | 608.82M |
| FCF Per Share | 19.67 |
Margins
Gross margin is 31.12%, with operating and profit margins of 21.19% and 19.17%.
| Gross Margin | 31.12% |
| Operating Margin | 21.19% |
| Pretax Margin | 22.57% |
| Profit Margin | 19.17% |
| EBITDA Margin | 21.19% |
| EBIT Margin | 21.19% |
| FCF Margin | 28.87% |
Dividends & Yields
MEDP does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | 3.93% |
| FCF Yield | 5.92% |
Analyst Forecast
The average price target for MEDP is $333, which is 7.9% higher than the current price. The consensus rating is "Hold".
| Price Target | $333 |
| Price Target Difference | 7.9% |
| Analyst Consensus | Hold |
| Analyst Count | 10 |
Scores
| Altman Z-Score | 6.4 |
| Piotroski F-Score | 7 |